| Ytd | 7.79% | |
| 1y | 33.05% |
| Open | 131.26 | Prev Close | 132.48 | Low | 129.90 | High | 131.89 | Mkt Cap | 17.56B |
| Vol | 615.21K | Avg Vol | 1.29M | EPS | 3.72 | P/E | 34.95 | Forward P/E | 16.31 |
| Beta | 1.08 | Short Ratio | 4.04 | Inst. Own | 79.94% | Dividend | 2.40 | Div Yield | 1.81 |
| Ex Div Date | 08-31 | Earning | 11-03 | 50-d Avg | 134.90 | 200-d Avg | 137.84 | 1yr Est | 167.06 |
JP Morgan analyst Chigusa Katoku downgrades DuPont de Nemours (NYSE:DD) from Overweight to Neutra
GAMMA Investing LLC lifted its position in DuPont de Nemours, Inc. (NYSE: DD) by 242.3% during the t
Moody National Bank Trust Division purchased a new position in shares of DuPont de Nemours, Inc. (NY
Citigroup analyst Patrick Cunningham maintains DuPont de Nemours (NYSE:DD) with a Buy and lowers
DuPont de Nemours (NYSE: DD - Get Free Report) and Marubeni (OTCMKTS:MARUY - Get Free Report) are bo
WILMINGTON, Del., Oct. 6, 2026 /PRNewswire/ -- DuPont (NYSE: DD) will release its third quarter 2026
UBS analyst Joshua Spector maintains DuPont de Nemours (NYSE:DD) with a Buy and lowers the price
Awards recognize continued excellence in healthcare packaging initiatives that utilize Tyvek ® mater
DuPont de Nemours (NYSE: DD - Get Free Report) and Mitsubishi (OTCMKTS:MSBHF - Get Free Report) are
Chemours PFAS settlement lifts shares as the $455 million deal clarifies liabilities, payment timing
The Chemours Company (NYSE:CC) (the "Company") today announced that, along with DuPont de Ne
JP Morgan analyst Chigusa Katoku maintains DuPont de Nemours (NYSE:DD) with a Overweight and rais
RBC Capital analyst Arun Viswanathan maintains DuPont de Nemours (NYSE:DD) with a Outperform and
https://www.ft.com/content/77f00cf3-f2e6-4dcb-bf0d-1631ca45dd9c?syn-25a6b1a6=1&_gl=1*1lkg4gt*_up
UBS analyst Joshua Spector maintains DuPont de Nemours (NYSE:DD) with a Buy and raises the price
DuPont Earnings Outlook improves after a Q2 beat, but a narrower sales range and currency headwinds
DuPont de Nemours (NYSE:DD) is looking for Q3 Adj EPS of $1.80-$1.90 vs $1.93 analyst estimate. sees
DuPont de Nemours (NYSE:DD) reported second-quarter financial results on Tuesday. The transcript fro
DuPont de Nemours (NYSE:DD) raises FY2026 Adj EPS guidance from $7.02-$7.16 to $7.17-$7.32 vs $7.13
Spinning off business units for companies can unlock shareholder value. Market expert Jay Woods shar
Morgan Stanley analyst Vincent Andrews maintains DuPont de Nemours (NYSE:DD) with a Equal-Weight
Qnity Electronics shares rose 2.85% after hours as investors reacted to the CEO’s upbeat comments on
DuPont de Nemours (NYSE:DD) affirms FY2026 Adj EPS guidance from $7.02-$7.16 to $7.02-$7.16 vs $7.17
RBC Capital analyst Arun Viswanathan maintains DuPont de Nemours (NYSE:DD) with a Outperform and
UBS analyst Joshua Spector maintains DuPont de Nemours (NYSE:DD) with a Buy and raises the price
DuPont (NYSE: DD) beats Q1 estimates with $1.68B in sales and 15% EBITDA growth. Shares rose over 7%
DuPont de Nemours (NYSE:DD) is looking for Q2 Adj EPS of $0.59 vs $0.58 analyst estimate. sees sales
DuPont de Nemours (NYSE:DD) raises FY2026 Adj EPS guidance from $2.25-$2.30 to $2.35-$2.40 vs $2.27
DuPont (DD) shares slip premarket as risk appetite softens. Explore technical analysis, support leve
Women remain scarce in the C‑suite, with only a fraction of large U.S. companies led by female CEOs.
Expedia, SanDisk, and Penumbra led last week's large-cap gainers, with strong earnings and raise
After a brief and cautious rebound on Wednesday, risk-off sentiment returned sharply on Thursday, wi
https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20251027-1480741/1480741_hon-dd-
DuPont agreed to sell its Aramids business, including Kevlar and Nomex brands, to Arclin for $1.8B.
U.S.
DuPont completes a major expansion of photoresist manufacturing in Japan, nearly doubling capacity t
DuPont reports better-than-expected Q2 earnings, with sales up 2% Y/Y. Plans to split into 3 entitie
BofA Securities analyst raises DD's price target from $74 to $80, reiterating underperform ratin
Companies Reporting Before The Bell • BP (NYSE:BP) is projected to report quarterly earnings at $1.
Stocks experienced a modest surge amid the Federal Open Market Committee meeting Wednesday. The cent
Companies Reporting Before The Bell • GSK (NYSE:GSK) is expected to report quarterly earnings at $1
3M Company (NYSE: MMM), the American multinational conglomerate, is on the hook for a substantial se
Companies Reporting Before The Bell • Vanguard Extended Duration Treasury ETF (NYSE:EDV) is estimat